Covers ALS and Friedreich ataxia, emphasizing ALS’s combined UMN/LMN degeneration without sensory loss, key genetic and molecular mechanisms, hallmark findings, and management with riluzole, edaravone, and supportive...
Open this topic in Core Concepts